These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19239397)

  • 1. Colesevelam for the management of type 2 diabetes.
    Marrs JC
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):187-94. PubMed ID: 19239397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
    Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of colesevelam on lowering glycemia and lipids.
    Aggarwal S; Loomba RS; Arora RR
    J Cardiovasc Pharmacol; 2012 Feb; 59(2):198-205. PubMed ID: 21983746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of a prospective clinical trial program to evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus.
    Bays HE; Cohen DE
    Curr Med Res Opin; 2007 Jul; 23(7):1673-84. PubMed ID: 17588297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
    Marrs JC
    Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.
    Younk LM; Davis SN
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):515-25. PubMed ID: 22432790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.
    Wright WL
    Adv Nurse Pract; 2009 Nov; 17(11):suppl 1-16. PubMed ID: 20014684
    [No Abstract]   [Full Text] [Related]  

  • 8. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE
    Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
    Brunetti L; Hermes-Desantis ER
    Ann Pharmacother; 2010; 44(7-8):1196-206. PubMed ID: 20551301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review.
    Elkeles RS
    Diabet Med; 2014 Jul; 31(7):880. PubMed ID: 24588426
    [No Abstract]   [Full Text] [Related]  

  • 11. Colesevelam. GT 31104, CholestaGel.
    Drugs R D; 1999 Jun; 1(6):479-80. PubMed ID: 10566088
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study.
    Schwartz SL; Lai YL; Xu J; Abby SL; Misir S; Jones MR; Nagendran S
    Metab Syndr Relat Disord; 2010 Apr; 8(2):179-88. PubMed ID: 20059361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL.
    Goldberg RB
    Curr Diab Rep; 2009 Oct; 9(5):331-2. PubMed ID: 19793501
    [No Abstract]   [Full Text] [Related]  

  • 14. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
    Fonseca VA; Rosenstock J; Wang AC; Truitt KE; Jones MR
    Diabetes Care; 2008 Aug; 31(8):1479-84. PubMed ID: 18458145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
    Goldfine AB; Fonseca VA
    Postgrad Med; 2009 May; 121(3 Suppl 1):13-8. PubMed ID: 19494473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):5-6. PubMed ID: 19494471
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
    Dayer-Berenson L; Finckenor M
    Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.
    Handelsman Y; Abby SL; Jin X; Donovan JM; Jones MR
    Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.